The Finnish type of congenital nephrotic syndrome occurs due to gene mutations affecting the following protein
## **Core Concept**
The Finnish type of congenital nephrotic syndrome, also known as Congenital Nephrotic Syndrome of the Finnish type (CNF), is a rare genetic disorder characterized by massive proteinuria and nephrotic syndrome in the fetus and newborn. This condition primarily affects the structure and function of the glomerular filtration barrier. The underlying cause is related to mutations in a gene that encodes for a crucial component of the podocyte.
## **Why the Correct Answer is Right**
The correct answer, **NPHS1**, encodes for nephrin, a key protein component of the slit diaphragm of the podocytes in the glomeruli. Nephrin plays a critical role in maintaining the integrity of the glomerular filtration barrier, preventing the loss of albumin and other proteins into the urine. Mutations in the **NPHS1** gene lead to the absence or dysfunction of nephrin, resulting in the Finnish type of congenital nephrotic syndrome. This condition is characterized by the prenatal onset of massive proteinuria, hypoalbuminemia, and edema.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While **COL4A5** mutations are associated with Alport syndrome, another type of genetic kidney disease, it is not related to the Finnish type of congenital nephrotic syndrome.
- **Option B:** **WT1** gene mutations are associated with Denys-Drash syndrome and Frasier syndrome, which also affect kidney function but are not the cause of the Finnish type of congenital nephrotic syndrome.
- **Option D:** **CD2AP** is involved in the regulation of the glomerular filtration barrier but is not the specific gene associated with the Finnish type of congenital nephrotic syndrome.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that congenital nephrotic syndrome of the Finnish type presents with massive proteinuria and nephrotic syndrome immediately at birth, distinguishing it from other causes of nephrotic syndrome that typically present later in life. The condition often leads to end-stage renal disease early in life. Early diagnosis through genetic testing can help in family planning and management.
## **Correct Answer:** . **NPHS1**